Roche said the Phase II results help build the case for advancing CT-388 into late-stage testing, which is set to get underway this quarter.

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

A brief, calorie-restricted diet centered almost entirely on oats led to a surprisingly strong and lasting reduction in cholesterol in people with metabolic syndrome. A very short dietary intervention ...